Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 3
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Fypryst 50 mg - V/DCP/10/0006 KRKA, d.d., Novo mesto, Slovēnija QP53AX15 cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/10/0006-01 50 mg 3 Tūbiņa, 1 deva -
V/DCP/10/0006-02 50 mg 1 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0006-03 50 mg 6 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0006-04 50 mg 10 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0006-05 50 mg 20 Plastikāta tūbiņa, 1 deva -
Fypryst 67 mg - V/DCP/10/0007 KRKA, d.d., Novo mesto, Slovēnija QP53AX15 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/10/0007-01 67 mg 3 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0007-02 67 mg 1 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0007-03 67 mg 6 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0007-04 67 mg 10 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0007-05 67 mg 20 Plastmasas tūbiņa, 1 deva -
Fypryst 134 mg - V/DCP/10/0008 KRKA, d.d., Novo mesto, Slovēnija QP53AX15 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/10/0008-01 134 mg 3 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0008-02 134 mg 1 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0008-03 134 mg 6 Plastmasas tūbiņa, 1 deva -
V/DCP/10/0008-04 134 mg 10 Plastmasas tūbiņa, 1 deva -
V/DCP/10/0008-05 134 mg 20 Plastikāta tūbiņa, 1 deva -
Fypryst 268 mg - V/DCP/10/0009 KRKA, d.d., Novo mesto, Slovēnija QP53AX15 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/10/0009-01 268 mg 10 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0009-02 268 mg 1 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0009-03 268 mg 3 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0009-04 268 mg 6 Plastikāta tūbiņa, 1 deva -
V/DCP/10/0009-05 268 mg 20 Plastikāta tūbiņa, 1 deva -
BI-VAC 1 - V/NRP/02/1499 Fatro S.p.A., Itālija QI01AD07 poultry Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for oral solution
International name (active substance): Infectious Avian bronchitis virus, strain H120
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 13-Jun-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 87-130608LI (13-Jun-2008)
Labelling text: [PDF] 87-130608M (13-Jun-2008)
Summary of product characteristics: [PDF] 87-130608ZA (13-Jun-2008)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1499-01 1 Stikla flakons, 1000 deva -
V/NRP/02/1499-02 10 Stikla flakons, 1000 deva -
IBA-VAC - V/NRP/02/1498 Fatro S.p.A., Itālija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate for use in drinking water
International name (active substance): Live attenuated virus of Gumboro disease
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 13-Jun-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 90-130608LI (13-Jun-2008)
Labelling text: [PDF] 90-130608M (13-Jun-2008)
Summary of product characteristics: [PDF] 90-130608ZA (13-Jun-2008)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1498-01 1 Stikla flakons, 1000 deva -
V/NRP/02/1498-02 10 Stikla flakons, 1000 deva -
Buprelab 0.3 mg/ml V/MRP/23/0068 Labiana Life Sciences S.A., Spānija QN02AE01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Buprenorphine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Labiana Life Sciences S.A., Spānija
Date of authorisation/renewal: 20-Dec-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/23/0068-01 0,3 mg/ml 1 Stikla flakons, 10 ml -
V/MRP/23/0068-02 0,3 mg/ml 5 Stikla flakons, 10 ml -
V/MRP/23/0068-03 0,3 mg/ml 10 Stikla flakons, 10 ml -
Tullavis 25 mg/ml V/DCP/20/0054 Industrial Veterinaria, S.A., Spānija QJ01FA94 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0054-01 25 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/20/0054-02 25 mg/ml 1 Stikla flakons, 250 ml -
V/DCP/20/0054-03 25 mg/ml 1 Stikla flakons, 50 ml -
PestiGon Combo 67 mg / 60,3 mg - V/DCP/17/0014 Norbrook Laboratories (Ireland) Limited, Īrija QP53AX65 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 29-Mar-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 29032022LI (29-Mar-2022)
Labelling text: [DOCX] 29032022M (29-Mar-2022)
Summary of product characteristics: [DOCX] 29032022ZA (29-Mar-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0014-01 1 Pipete, 1 deva -
V/DCP/17/0014-02 2 Pipete, 1 deva -
V/DCP/17/0014-03 3 Pipete, 1 deva -
V/DCP/17/0014-04 4 Pipete, 1 deva -
V/DCP/17/0014-05 6 Pipete, 1 deva -
V/DCP/17/0014-06 8 Pipete, 1 deva -
V/DCP/17/0014-07 12 Pipete, 1 deva -
V/DCP/17/0014-08 24 Pipete, 1 deva -
Benamax Flavour 2.5 mg V/MRP/12/0021 LAVET Pharmaceuticals Ltd., Ungārija QC09AA07 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Benazepril hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lavet Pharmaceuticals, Ungārija
Date of authorisation/renewal: 02-Aug-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOC] 290716LI (20-Nov-2020)
Labelling text: [DOCX] 290716M (20-Nov-2020)
Summary of product characteristics: [DOCX] 290716ZA (20-Nov-2020)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0021-01 2,5 mg 1 Alumīnija blisteris, 14 tablete -
V/MRP/12/0021-02 2,5 mg 2 Alumīnija blisteris, 14 tablete -
V/MRP/12/0021-03 2,5 mg 4 Alumīnija blisteris, 14 tablete -
V/MRP/12/0021-04 2,5 mg 10 Alumīnija blisteris, 14 tablete -
Benamax Flavour 5 mg V/MRP/12/0022 LAVET Pharmaceuticals Ltd., Ungārija QC09AA07 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Benazepril hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lavet Pharmaceuticals, Ungārija
Date of authorisation/renewal: 02-Aug-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOC] 290716LI (20-Nov-2020)
Labelling text: [DOCX] 290716M (20-Nov-2020)
Summary of product characteristics: [DOCX] 290716ZA (20-Nov-2020)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0022-01 5 mg 1 Alumīnija blisteris, 14 tablete -
V/MRP/12/0022-02 5 mg 2 Alumīnija blisteris, 14 tablete -
V/MRP/12/0022-03 5 mg 4 Alumīnija blisteris, 14 tablete -
V/MRP/12/0022-04 5 mg 10 Alumīnija blisteris, 14 tablete -
Benamax Flavour 20 mg V/MRP/12/0023 LAVET Pharmaceuticals Ltd., Ungārija QC09AA07 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Benazepril hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lavet Pharmaceuticals, Ungārija
Date of authorisation/renewal: 02-Aug-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOC] 290716LI (20-Nov-2020)
Labelling text: [DOCX] 290716M (20-Nov-2020)
Summary of product characteristics: [DOCX] 290716ZA (20-Nov-2020)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0023-01 20 mg 1 Alumīnija blisteris, 7 tablete -
V/MRP/12/0023-02 20 mg 2 Alumīnija blisteris, 7 tablete -
V/MRP/12/0023-03 20 mg 4 Alumīnija blisteris, 7 tablete -
V/MRP/12/0023-04 20 mg 10 Alumīnija blisteris, 7 tablete -
Noroclav - V/DCP/18/0063 Norbrook Laboratories (Ireland) Limited, Īrija QJ51RV01 lactating cows Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Amoxicillin, Clavulanic acid, Prednisolone
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Laboratories (Ireland) Limited, Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (16-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0063-01 3 Injektors, 3 g/deva -
V/DCP/18/0063-02 12 Injektors, 3 g/deva -
V/DCP/18/0063-03 24 Injektors, 3 g/deva -
V/DCP/18/0063-04 120 Injektors, 3 g/deva -
Ceftiomax 50 mg/ml V/MRP/10/0003 Laboratorios Calier, S.A., Spānija QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija
Date of authorisation/renewal: 01-Nov-2013
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 281013LI (01-Nov-2013)
Labelling text: [PDF] 281013M (01-Nov-2013)
Summary of product characteristics: [PDF] 281013ZA (01-Nov-2013)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/10/0003-01 50 mg/ml 1 Stikla flakons, 100 ml -
V/MRP/10/0003-02 50 mg/ml 1 Stikla flakons, 250 ml -
Dormostop 5 mg/ml V/DCP/23/0036 Alfasan Nederland BV, Nīderlande QV03AB90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Atipamezole hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 27-Jul-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jul-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (27-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0036-01 1 Stikla flakons, 5 ml -
V/DCP/23/0036-02 1 Stikla flakons, 10 ml -
V/DCP/23/0036-03 1 Stikla flakons, 20 ml -
Dophacyl 1000 mg/g V/DCP/23/0035 Dopharma Research B.V., Nīderlande QN02BA04 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: powder for use in drinking water/ milk
International name (active substance): Sodium salicylate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 27-Jul-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] M_LI (27-Jul-2023)
Labelling text: [DOCX] M_LI (27-Jul-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Jul-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0035-01 1 Polipropilēna konteiners, 500 g -
V/DCP/23/0035-02 1 Polipropilēna konteiners, 1000 g -
V/DCP/23/0035-03 1 Polipropilēna spainis, 1 kg -
V/DCP/23/0035-04 1 Polipropilēna spainis, 2,5 kg -
V/DCP/23/0035-05 1 Polipropilēna spainis, 5 kg -
Uriphex 50 mg/ml V/DCP/23/0044 Alfasan Nederland BV, Nīderlande QG04BX91 dogs Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Phenylpropanolamine hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 25-Aug-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0044-01 50 mg/ml 1 ABPE pudele, 30 ml -
V/DCP/23/0044-02 50 mg/ml 1 ABPE pudele, 60 ml -
V/DCP/23/0044-03 50 mg/ml 1 ABPE pudele, 100 ml -
Canigen L - V/DCP/17/0007 VIRBAC, Francija QI07AB01 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated Leptospira interrogans serogroup Canicola serovar Canicola, strain 601903,Inactivated Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae, strain 601895
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 24-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0007-01 1 Stikla flakons (kartona kastē), 1 deva -
V/DCP/17/0007-03 10 Stikla flakons (kartona kastē), 1 deva -
V/DCP/17/0007-04 25 Stikla flakons (kartona kastē), 1 deva -
V/DCP/17/0007-05 50 Stikla flakons (kartona kastē), 1 deva -
V/DCP/17/0007-06 100 Stikla flakons (kartona kastē), 1 deva -
CEVAC IBird - V/DCP/13/0031 Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija QI01AD07 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilizate for suspension
International name (active substance): Live attenuated infectious bronchitis virus, strain 1/96
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 01-Aug-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Feb-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0031-01 1 Stikla flakons, 500 deva -
V/DCP/13/0031-02 10 Stikla flakons, 500 deva -
V/DCP/13/0031-03 20 Stikla flakons, 500 deva -
V/DCP/13/0031-04 1 Stikla flakons, 1000 deva -
V/DCP/13/0031-05 10 Stikla flakons, 1000 deva -
V/DCP/13/0031-06 20 Stikla flakons, 1000 deva -
V/DCP/13/0031-07 1 Stikla flakons, 2500 deva -
V/DCP/13/0031-08 10 Stikla flakons, 2500 deva -
V/DCP/13/0031-09 20 Stikla flakons, 2500 deva -
V/DCP/13/0031-10 1 Stikla flakons, 5000 deva -
V/DCP/13/0031-11 10 Stikla flakons, 5000 deva -
V/DCP/13/0031-12 20 Stikla flakons, 5000 deva -
V/DCP/13/0031-13 1 Stikla flakons, 10000 deva -
V/DCP/13/0031-14 10 Stikla flakons, 10000 deva -
V/DCP/13/0031-15 20 Stikla flakons, 10000 deva -
DORAXX 25 mg/ml V/DCP/21/0073 Dopharma Research B.V., Nīderlande QJ01FA94 pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release MEVET S.A.U, Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 291121LI (29-Nov-2021)
Labelling text: [DOCX] 291121M (29-Nov-2021)
Summary of product characteristics: [DOCX] 291121ZA (29-Nov-2021)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0073-01 100 ml 1 Stikla flakons, 100 ml -

3082 records